Atlas Trials

A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of Oral Teslanbaicin in Patients With Radiation Proctitis

Clinical trial NCT06974123 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT06974123
Sponsor
The First Affiliated Hospital of Xinxiang Medical College
Status
ENROLLING_BY_INVITATION
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Safety
Start date
2024-10-15
Primary completion
2026-12-31
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.